Role of Femoral Vein Wall Thickness and Inflammatory Markers in Patients With Behcet Disease
Recruiting
- Conditions
- Behçet
- Registration Number
- NCT06721234
- Lead Sponsor
- Sohag University
- Brief Summary
Evaluation of femoral vein wall thickness and inflammatory indices in patients with Behcet disease and assessment of their relation to the disease activity and related some clinical manifestations
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
- Patients fulfill the International Criteria for Behcet's Disease (ICBD)
- Age above 18 years old
- Patients cooperative and can answer questions
- Patients who are able and willing to give informed consent
Exclusion Criteria
- Other rheumatological and vascular diseases
- Patients with abnormal hepatic or renal function tests , hyperlipidemia and impaired coagulation tests
- Patients with hypertension , diabetes mellitus , malignant and active infectious diseases
- Patients who are using aspirin and other platelet active drygs during the previous 6 months
- patients who are not able and willing to give written consent
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Femoral Vein Wall thickness One week
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
How do inflammatory markers like IL-6 and CRP correlate with femoral vein wall thickness in Behçet disease patients?
What biomarkers predict disease activity in Behçet’s patients based on femoral vein wall thickness measurements?
How does femoral vein wall thickness compare to traditional vascular markers in predicting thrombotic events in Behçet vasculitis?
Are specific inflammatory pathways (e.g., TNF-α, IL-1β) linked to vein wall remodeling in Behçet-related vasculopathy?
What anti-inflammatory therapies target pathways associated with femoral vein wall thickening in Behçet disease?
Trial Locations
- Locations (1)
Sohag university
🇪🇬Sohag, Egypt